Cell-type-specific regulation of APOE levels in human neurons by the Alzheimer's disease risk gene SORL1
Lee, H.; Aylward, A. J.; Pearse, R. V.; Hsieh, Y.-C.; Augur, Z. M.; Benoit, C. R.; Chou, V.; Knupp, A.; Pan, C.; Goberdhan, S.; Duong, D. M.; Seyfried, N. T.; Bennett, D. A.; Klein, H.-U.; De Jager, P. L.; Menon, V.; Young, J. E.; Young-Pearse, T. L.
Show abstract
SORL1 is strongly implicated in the pathogenesis of Alzheimers disease (AD) through human genetic studies that point to an association of reduced SORL1 levels with higher risk for AD. To interrogate the role(s) of SORL1 in human brain cells, SORL1 null iPSCs were generated, followed by differentiation to neuron, astrocyte, microglia, and endothelial cell fates. Loss of SORL1 led to alterations in both overlapping and distinct pathways across cell types, with the greatest effects in neurons and astrocytes. Intriguingly, SORL1 loss led to a dramatic neuron-specific reduction in APOE levels. Further, analyses of iPSCs derived from a human aging cohort revealed a neuron-specific linear correlation between SORL1 and APOE RNA and protein levels, a finding validated in human post-mortem brain. Pathway analysis implicated intracellular transport pathways and TGF- {beta}/SMAD signaling in the function of SORL1 in neurons. In accord, enhancement of retromer-mediated trafficking and autophagy rescued elevated phospho-tau observed in SORL1 null neurons but did not rescue APOE levels, suggesting that these phenotypes are separable. Stimulation and inhibition of SMAD signaling modulated APOE RNA levels in a SORL1-dependent manner. These studies provide a mechanistic link between two of the strongest genetic risk factors for AD.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cystatin F (Cst7) drives sex-dependent changes in microglia in an amyloid-driven model of Alzheimer's Disease 96%
- Aβ-driven nuclear pore complex dysfunction alters activation of necroptosis proteins in a mouse model of Alzheimer's Disease 96%
- APOE Expression and Secretion are Modulated by Mitochondrial Dysfunction 96%
Similar papers in this journal
Similar papers in this journal
- A Trem2*R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques 96%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 96%
- TREM2-H157Y Increases Soluble TREM2 Production and Reduces Amyloid Pathology 95%
Similar papers in this journal
- Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model 95%
- Tau aggregates are RNA-protein assemblies that mis-localize multiple nuclear speckle components 94%
- The Alzheimers Disease Risk Genes MS4A4A And MS4A6A Cooperate to Negatively Regulate Trem2 and Microglia states 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.